Peter Honig - 24 May 2023 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/ Nancy Smith, Attorney-in-Fact for Peter Honig
Issuer symbol
KPTI
Transactions as of
24 May 2023
Net transactions value
$0
Form type
4
Filing time
25 May 2023, 16:06:10 UTC
Previous filing
24 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPTI Nonstatutory Stock Option (right to buy) Award $0 +34,000 $0.000000 34,000 24 May 2023 Common Stock 34,000 $2.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 100% of the underlying shares on May 24, 2024.